Department of Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden,
Tech Coloproctol. 2013 Oct;17(5):589-92. doi: 10.1007/s10151-013-0985-z. Epub 2013 Mar 22.
Sacral nerve stimulation (SNS) has become an established therapy worldwide for the treatment for fecal incontinence. A large number of papers have been published over the years, and SNS is generally considered very effective with improved continence and quality of life for most patients. However, the results are mostly expressed in the semi-quantitative terms, that is, patients' diaries translated into score points. The clinical value of SNS is questionable, especially as the patient groups are usually small and/or etiologically heterogenic and the follow-up period mostly short. The Health Technology Assessment organization in the west region of Sweden has recently evaluated the SNS with regard to evidence, efficacy and risks. Economic and ethical aspects raise serious questions on this expensive and not entirely risk-free treatment in routine medical care. Similar criticism has also been raised by other reviewers proposing a more thorough scientific assessment with well-designed randomized trials and comparison with other similar methods of treatment.
骶神经刺激(SNS)已成为全球治疗粪便失禁的一种既定疗法。多年来已经发表了大量的论文,SNS 通常被认为对大多数患者非常有效,可以提高他们的生活质量和控制能力。然而,结果大多以半定量术语表示,即患者日记翻译成得分点。SNS 的临床价值值得怀疑,尤其是因为患者群体通常较小和/或病因异质,并且随访期大多较短。瑞典西部地区的医疗技术评估机构最近对 SNS 的证据、疗效和风险进行了评估。经济和伦理方面对这种昂贵且并非完全无风险的常规医疗护理治疗方法提出了严重质疑。其他评论员也提出了类似的批评,他们建议进行更全面的科学评估,包括精心设计的随机试验,并与其他类似的治疗方法进行比较。